Next-generation sequencing (NGS) techniques for pre-symptomatic identification of genetic diseases in newborns
to explore equity and ethical issues in the application of the new techniques, to inform healthcare decisions by families, carers, and policymakers.
Authors
- Roger F. Soll (ORCID: https://orcid.org/0000-0003-0288-3014)
- Michelle Fiander (ORCID: https://orcid.org/0000-0002-3579-9292)
- Matteo Bruschettini (ORCID: https://orcid.org/0000-0002-4775-872X)
- Sara Pessano
- Karsten Juhl Jørgensen (ORCID: https://orcid.org/0000-0001-8554-0388)
- Francesca Faravelli
- Maria Boldor
Institutions
- University of Vermont (US)
- University of Southern Denmark (DK)
- Lund University (SE)
- University of Pavia (IT)
- Istituto Giannina Gaslini (IT)
- Vermont Oxford Network (US)
- Centre Hospitalier Universitaire de Reims (FR)
- Skåne University Hospital (SE)
- Cochrane (DK)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Université de Reims Champagne-Ardenne (FR)
Publication Details
- Journal
- Cochrane Database of Systematic Reviews
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1002/14651858.cd016118
- Primary Topic
- Metabolism and Genetic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00